Ariel Ruiz i Altaba

University of Geneva, Geneva, Switzerland 
"sonic hedgehog, cancer, stem cells"
"Ariel Ruiz i Altaba"
Mean distance: 106866
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Melotti A, Mas C, Kuciak M, et al. (2014) The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. Embo Molecular Medicine. 6: 1263-78
Duquet A, Melotti A, Mishra S, et al. (2014) A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12. Embo Molecular Medicine. 6: 882-901
Aberger F, Ruiz I Altaba A. (2014) Context-dependent signal integration by the GLI code: the oncogenic load, pathways, modifiers and implications for cancer therapy. Seminars in Cell & Developmental Biology. 33: 93-104
Verbeni M, Sánchez O, Mollica E, et al. (2013) Morphogenetic action through flux-limited spreading. Physics of Life Reviews. 10: 457-75
Verbeni M, Sánchez O, Mollica E, et al. (2013) On flux-limited morphogenesis. Reply to the comments on "Morphogenetic action through flux-limited spreading". Physics of Life Reviews. 10: 495-497
Ruiz i Altaba A. (2011) Hedgehog signaling and the Gli code in stem cells, cancer, and metastases. Science Signaling. 4: pt9
Mas C, Ruiz i Altaba A. (2010) Small molecule modulation of HH-GLI signaling: current leads, trials and tribulations. Biochemical Pharmacology. 80: 712-23
Stecca B, Ruiz I Altaba A. (2010) Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. Journal of Molecular Cell Biology. 2: 84-95
Varnat F, Zacchetti G, Ruiz i Altaba A. (2010) Hedgehog pathway activity is required for the lethality and intestinal phenotypes of mice with hyperactive Wnt signaling. Mechanisms of Development. 127: 73-81
Ruiz i Altaba A, Varnat F. (2010) On hedgehogs and human cancer Embo Molecular Medicine. 2: 386-387
See more...